Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist treats diseases, in the widest sense, and some cosmetic problems of the skin, scalp, hair, and nails.
Market Analysis and Insights: Global Dermatology Diagnostic Devices and Therapeutics Market
In 2020, the global Dermatology Diagnostic Devices and Therapeutics market size was US$ 944.4 million and it is expected to reach US$ 1278.9 million by the end of 2027, with a CAGR of 4.0% between 2021 and 2027
Global Dermatology Diagnostic Devices and Therapeutics Scope and Market Size
The global Dermatology Diagnostic Devices and Therapeutics market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology Diagnostic Devices and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
Segment by Type
Dermatoscopes
Microscopes
Trichoscopes
Imaging Equipment
Antibacterial Agents
Antifungal Agents
Antiviral Agents
Corticosteroids
Retinoids
Immunosuppressants
Segment by Application
Hospitals
Clinics
Others
By Company
Agfa
Astellas Pharma
Cutera
Dino-Lite
Galderma
Genentech
Stiefel
LEO Pharma
Michelson Diagnostics
Novartis
Bausch Health
Canfield Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Dermatology Diagnostic Devices and Therapeutics Market
In 2020, the global Dermatology Diagnostic Devices and Therapeutics market size was US$ 944.4 million and it is expected to reach US$ 1278.9 million by the end of 2027, with a CAGR of 4.0% between 2021 and 2027
Global Dermatology Diagnostic Devices and Therapeutics Scope and Market Size
The global Dermatology Diagnostic Devices and Therapeutics market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology Diagnostic Devices and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
Segment by Type
Dermatoscopes
Microscopes
Trichoscopes
Imaging Equipment
Antibacterial Agents
Antifungal Agents
Antiviral Agents
Corticosteroids
Retinoids
Immunosuppressants
Segment by Application
Hospitals
Clinics
Others
By Company
Agfa
Astellas Pharma
Cutera
Dino-Lite
Galderma
Genentech
Stiefel
LEO Pharma
Michelson Diagnostics
Novartis
Bausch Health
Canfield Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
